PT  - JOURNAL ARTICLE
AU  - Jie Yang
AU  - Shicheng Fan
AU  - Yifei Zhang
AU  - Min Huang
AU  - Yue Gao
AU  - Huichang Bi
TI  - Chronic treatment with WY-14643 induces tumorigenesis and triglyceride accumulation in mouse livers
AID  - 10.1124/dmd.122.000908
DP  - 2022 Jan 01
TA  - Drug Metabolism and Disposition
PG  - DMD-AR-2022-000908
4099  - http://dmd.aspetjournals.org/content/early/2022/10/02/dmd.122.000908.short
4100  - http://dmd.aspetjournals.org/content/early/2022/10/02/dmd.122.000908.full
AB  - Peroxisome proliferator-activated receptor α (PPARα) is closely related to lipid metabolism and various liver diseases. Previous study has shown that chronic treatment with PPARα agonist WY-14643 can induce liver tumors in rodents, but the implications of this process on lipid metabolism in the liver remain unclear. Thus, this study aimed to explore the influences of chronic treatment with WY-14643 on the liver and hepatic lipid metabolism. Wild-type C57BL/6 mice were treated with WY-14643 (100 mg/kg/week, i.p.) or corn oil, and liver and serum samples were collected for testing after 42-week WY-14643 treatment. The results showed that hepatomegaly, liver tumors with mild liver injury, and hepatocyte proliferation were induced in mice treated with WY-14643. The mRNA and protein expression levels of PPARα downstream targets acyl-CoA oxidase 1 (ACOX1) and cytochrome P450 4A (CYP4A) were significantly upregulated in the WY-14643-treated group. Lipidomic analysis revealed that chronic treatment with WY-14643 disturbed lipid homeostasis, especially triglycerides (TGs), which were significantly elevated after WY-14643 treatment. Moreover, TG homeostasis-related genes were significantly increased in the WY-14643-treated group. In conclusion, these findings demonstrated that hepatomegaly and liver tumors induced by chronic treatment with WY-14643 in mice are accompanied by hepatocyte proliferation and TG accumulation. Significance Statement The present study clearly demonstrated that sustained PPARα activation by chronic treatment with WY-14643 induces hepatomegaly and liver tumors with TG accumulation by regulating lipid homeostasis-related genes in mice. These findings may help to clarify the influences of sustained PPARα activation on liver lipid homeostasis and provide data for the clinically rational use of drugs that can activate PPARα.